Hôpital Européen Georges-Pompidou-ko ikertzaileekin lankidetzan egindako argitalpenak (16)

2024

  1. Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC

    European Journal of Heart Failure, Vol. 26, Núm. 1, pp. 18-33

  2. Tricuspid valve disease and cardiac implantable electronic devices

    European Heart Journal, Vol. 45, Núm. 5, pp. 346-365

2021

  1. Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry

    Internal and Emergency Medicine, Vol. 16, Núm. 3, pp. 591-599

2020

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)

    European Heart Journal, Vol. 41, Núm. 4, pp. 543-603

  2. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

    The Lancet, Vol. 396, Núm. 10266, pp. 1895-1904

  3. Long-term outcomes of chronic coronary syndrome worldwide: Insights from the international CLARIFY registry

    European Heart Journal, Vol. 41, Núm. 3, pp. 347-355

2019

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

    European Respiratory Journal, Vol. 54, Núm. 3

2018

  1. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis

    European Heart Journal, Vol. 39, Núm. 15, pp. 1224-1245

  2. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy

    Archives of Cardiovascular Diseases, Vol. 111, Núm. 2, pp. 74-84

2017

  1. Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement

    Journal of the American College of Cardiology, Vol. 69, Núm. 16, pp. 2067-2087

  2. Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF

    Journal of the American College of Cardiology, Vol. 69, Núm. 4, pp. 409-419

2016

  1. Characteristics and outcomes of atrial fibrillation patients with or without specific symptoms: Results from the PREFER in AF registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 2, Núm. 4, pp. 299-305

2014

  1. Differences among western European countries in anticoagulation management of atrial fibrillation: Data from the PREFER IN AF Registry

    Thrombosis and Haemostasis, Vol. 111, Núm. 5, pp. 833-841

  2. Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe

    Heart, Vol. 100, Núm. 20, pp. 1625-1635

  3. Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: Primary results of the PREvention of thromboemolic events-European Registry in Atrial Fibrillation (PREFER in AF)

    Europace, Vol. 16, Núm. 1, pp. 6-14

2013

  1. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

    European Heart Journal, Vol. 34, Núm. 28, pp. 2159-2219